# Low or High Dose of Dexamethasone in Patients With Respiratory Failure by COVID-19

> **NCT04726098** · PHASE4 · COMPLETED · sponsor: **Manuel Taboada Muñiz** · enrollment: 198 (actual)

## Conditions studied

- Covid19
- Corticosteroids

## Interventions

- **DRUG:** Dexamethasone high dose
- **DRUG:** Dexamethasone low dose

## Key facts

- **NCT ID:** NCT04726098
- **Lead sponsor:** Manuel Taboada Muñiz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-15
- **Primary completion:** 2021-08-31
- **Final completion:** 2021-08-31
- **Target enrollment:** 198 (ACTUAL)
- **Last updated:** 2021-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04726098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04726098, "Low or High Dose of Dexamethasone in Patients With Respiratory Failure by COVID-19". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04726098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*